Evaluation of an implementation of PRODIGY phase two

PRODIGY is a prescribing decision-support tool that encourages evidence-based cost-effective prescribing and supports information for patients with patient information leaflets. Following two successful pilot phases, the Department of Health has announced plans for a nation-wide rollout to all gener...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Proceedings. AMIA Symposium. - 1998. - (1999) vom: 23., Seite 604-8
1. Verfasser: Rogers, J (VerfasserIn)
Weitere Verfasser: Jain, N L, Hayes, G M
Format: Aufsatz
Sprache:English
Veröffentlicht: 1999
Zugriff auf das übergeordnete Werk:Proceedings. AMIA Symposium
Schlagworte:Journal Article
LEADER 01000naa a22002652 4500
001 NLM104964219
003 DE-627
005 20231222133639.0
007 tu
008 231222s1999 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0350.xml 
035 |a (DE-627)NLM104964219 
035 |a (NLM)10566430 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Rogers, J  |e verfasserin  |4 aut 
245 1 0 |a Evaluation of an implementation of PRODIGY phase two 
264 1 |c 1999 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 01.02.2000 
500 |a Date Revised 30.11.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a PRODIGY is a prescribing decision-support tool that encourages evidence-based cost-effective prescribing and supports information for patients with patient information leaflets. Following two successful pilot phases, the Department of Health has announced plans for a nation-wide rollout to all general practitioners in the UK. This paper describes the implementation and evaluation of PRODIGY Phase Two by AAH Meditel, one of the five participating GP system vendors. Based on the results and feedback from Phase One, Meditel made a number of changes to the software and training for Phase Two. The results showed Meditel's implementation of Phase Two was significantly better than the implementation of the other vendors (27% use versus 13% use), and also significantly better than its own implementation of Phase One (27% use versus 9.3% use). Patient information leaflets were issued 5.7% of the times versus 2.3% for the other vendors and 1.0% for Phase One. Detailed log files enabled the evaluation of the implementation of both phases and the software and training improvements made in Phase Two, and are recommended for the successful implementation of any clinical decision-support system project 
650 4 |a Journal Article 
700 1 |a Jain, N L  |e verfasserin  |4 aut 
700 1 |a Hayes, G M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Proceedings. AMIA Symposium  |d 1998  |g (1999) vom: 23., Seite 604-8  |w (DE-627)NLM098642928  |x 1531-605X  |7 nnns 
773 1 8 |g year:1999  |g day:23  |g pages:604-8 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |j 1999  |b 23  |h 604-8